Reduced expression of miR-30c-5p promotes hepatocellular carcinoma progression by targeting RAB32
Hepatocellular carcinoma (HCC) remains among the most lethal of human cancers, despite recent advances in modern medicine. miR-30c-5p is frequently dysregulated in different diseases. However, the effects and the underlying mechanism of miR-30c-5p in HCC are still elusive. Here, we show that miR-30c...
Saved in:
Main Authors: | Zheng He (Author), Meng Tian (Author), Xuan Fu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MiR-375 and Doxorubicin Co-delivered by Liposomes for Combination Therapy of Hepatocellular Carcinoma
by: Yin-Ping Fan, et al.
Published: (2017) -
Enhanced expression of miR-889 forecasts an unfavorable prognosis and facilitates cell progression in hepatocellular carcinoma
by: He Wang, et al.
Published: (2021) -
Expression Patterns of miR181a and miR30d in Patients with Breast Cancer
by: Alireza Tavakolpournegari, et al.
Published: (2022) -
Expression of miR-127, miR-154, and miR-183 in Medullary Thy-roid Carcinoma Tumors
by: Mahsa RAHMANI SAMANI, et al.
Published: (2021) -
Interactive role of miR‐29, miR‐93, miR‐205, and VEGF in salivary adenoid cystic carcinoma
by: Parisa Bayat, et al.
Published: (2023)